About Us.
i-RNA is a proud UWO spin-off created in London, Ontario, the birth place of insulin, around Dr. Subrata Chakrabarti (Google Scholar Profile)'s invention, driven by a passion for scientific discovery and a commitment to patient care.
At i-RNA, we are dedicated to the development of innovative diagnosis and treatments that improve patient outcomes, ensuring that we prioritize the health and well-being of the patients we serve.
Our Goals.
Our vision is to create a better world seen better by everyone
We aim to:
-
Improve eye disease outcomes and prognosis
-
Enhance patient experience and compliance
-
Lower healthcare costs
Meet Our Core Team.
At the heart of our innovative solutions is a diverse team of passionate scientists, researchers, and industry experts. With a shared commitment to advancing scientific knowledge, our team combines deep scientific knowledge with innovative methodologies to tackle some of the most pressing challenges in diabetic retinopathy today. We are dedicated to fostering a collaborative environment where creativity and expertise converge, driving forward our mission to improve lives through groundbreaking advancements in diabetic retinopathy.
Dr. Subrata Chakrabarti
Cofounder & Chair
Professor, Western University
Dr. Ting Ling
Cofounder & CEO
Ruby Zhao
Director of Business Development
Dr. Francis Feng
Senior Scientist, Western University
Sisi Guo
Admin & Project Coordinator
Advisors.
Dr. John Gonder
Ophthalmologist
Associate professor, Western University
Dr. Arup Das
Ophthalmologist
Professor, University of New Mexico
Dr. Aimin Xu
Professor, Hong Kong University
Dr. Colin Macaulay
Business Development Manager
WORLDiscoveries, Western University
Research Associates in
the Chakrabarti Lab.
Dr. Charlie Chen
Scientist
Eric Wang
Ph.D Candidate, Scientist
Working With the Best Partners.
_edited.jpg)